Pioneering treatment uses water to remove cancerous cells

• A groundbreaking trial for Aquablation, a prostate cancer treatment utilising robotics, AI, and real-time imaging, has launched in the UK.
• The therapy aims to offer a curative option with fewer side effects, such as erectile dysfunction and urinary problems, compared to traditional radical prostatectomy.
• The Royal Marsden NHS Foundation Trust in London is the first European hospital to recruit a patient for the global trial.
• It will involve 280 patients across seven countries.
• Aquablation works by using a robotic-assisted, high-pressure waterjet to precisely remove cancerous tissue while preserving surrounding nerves and muscles.

IN FULL

New cancer treatment with fewer side effects to be trialled in UK